CONDUCTUS INC
PRE 14A, 1998-04-30
ELECTRONIC COMPONENTS, NEC
Previous: BT PYRAMID MUTUAL FUNDS, 485BPOS, 1998-04-30
Next: WATSON PHARMACEUTICALS INC, S-3/A, 1998-04-30



<PAGE>

                                  SCHEDULE 14A
                                 (Rule 14a-101)
                    INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION

          Proxy Statement Pursuant to Section 14(a) of the Securities
                              Exchange Act of 1934

Filed by registrant /x/

Filed by a party other than the registrant / /


Check the appropriate box:

/X/  Preliminary proxy statement

/ /  Definitive proxy statement

/ /  Definitive additional materials

/ /  Soliciting material pursuant to Rule 14a-11(c) or Rule 14a-12
- -------------------------------------------------------------------------------

CONDUCTUS INC.
- ----------------------
(Name of Registrant as Specified in Its Charter)


- ----------------------
(Name of Person(s) Filing Proxy Statement)
- -------------------------------------------------------------------------------
Payment of filing fee (Check the appropriate box):

      /x/   No fee required.

      / /   $500 per each party to the controversy pursuant to Exchange Act 
            Rule 14a-6(i)(3).

      / /   Fee computed on table below per Exchange Act Rules 14a-6(i)(4) 
            and 0-11.

- -------------------------------------------------------------------------------
      (1)   Title of each class of securities to which transaction applies:

- -------------------------------------------------------------------------------
      (2)   Aggregate number of securities to which transaction applies:

- -------------------------------------------------------------------------------
      (3)   Per unit price or other underlying value of transaction computed 
            pursuant to Exchange Act Rule 0-11:(1)

- -------------------------------------------------------------------------------
      (4)   Proposed maximum aggregate value of transaction:

- -------------------------------------------------------------------------------
      / /   Check box if any part of the fee is offset as provided by 
            Exchange Act Rule 0-11(a)(2) and identify the filing for which 
            the offsetting fee was paid previously. Identify the previous 
            filing by registration number, or the form or schedule and the date 
            of its filing.

- -------------------------------------------------------------------------------
      (1)   Amount previously paid:

- -------------------------------------------------------------------------------
      (2)   Form, schedule or registration statement no.:

- -------------------------------------------------------------------------------
      (3)   Filing party:

- -------------------------------------------------------------------------------
      (4)   Date filed:

- -------------------------------------------------------------------------------
(1)  Set forth the amount on which the filing fee is calculated and state how 
     it was determined.
<PAGE>

                                  [CONDUCTUS LOGO]

                       NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
                              TO BE HELD ON MAY 29, 1998


TO THE STOCKHOLDERS OF CONDUCTUS, INC.:

NOTICE IS HEREBY GIVEN that the 1998 Annual Meeting of Stockholders of 
CONDUCTUS, INC. (the "Company"), will be held on Friday, May 29, 1998, at 
3:00 p.m. local time (the "Annual Meeting"), at the Company's administrative 
offices located at 965 West Maude Avenue, Sunnyvale, California 94086 for the 
following purposes, as more fully described in the Proxy Statement 
accompanying this Notice:

(1)  To elect directors of the Company;

(2)  To approve an amendment to and restatement of the Company's Restated 
     Certificate of Incorporation (i) to increase the number of shares of 
     Common Stock that the Company is authorized to issue from 11,000,000 to 
     20,000,000, and (ii) to increase the number of shares of Preferred Stock 
     that the Company is authorized to issue from 1,000,000 to 5,000,000;

(3)  To approve amendments to the Company's 1992 Stock Option/Stock Issuance 
     Plan to change the maximum number of options for shares of Common Stock 
     which may be granted to a single individual to 750,000 in any one 
     calendar year from 240,000 over the life of the Plan and to permit 
     discretionary option grants to non-employee directors;

(4)  To ratify the appointment of Coopers & Lybrand L.L.P. as the Company's 
     independent auditors for the fiscal year ending December 31, 1998; and

(5)  To transact such other business as may properly come before the meeting 
     or any adjournment or adjournments thereof.

Only stockholders of record at the close of business on April 16, 1998, are 
entitled to notice of and to vote at the Annual Meeting. The stock transfer 
books will not be closed between the record date and the date of the Annual 
Meeting. A list of stockholders entitled to vote at the Annual Meeting will 
be available for inspection at the executive offices of the Company for a 
period of ten days before the Annual Meeting.

All stockholders are cordially invited to attend the Annual Meeting in 
person. Whether or not you plan to attend, please sign and return the 
enclosed Proxy as promptly as possible in the envelope enclosed for your 
convenience. Should you receive more than one proxy because your shares are 
registered in different names and addresses, each proxy should be signed and 
returned to assure that all your shares will be voted. You may revoke your 
proxy at any time prior to the Annual Meeting. If you attend the Annual 
Meeting and vote by ballot, your proxy will be revoked automatically and only 
your vote at the Annual Meeting will be counted.

                                       BY ORDER OF THE BOARD OF DIRECTORS



                                       Charles E. Shalvoy
                                       President and Chief Executive Officer

         , 1998

YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES YOU OWN. 
PLEASE READ THE ATTACHED PROXY STATEMENT CAREFULLY, COMPLETE, SIGN AND DATE 
THE ENCLOSED PROXY AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE ENCLOSED 
ENVELOPE. 

<PAGE>

                              PROXY STATEMENT

<TABLE>
<CAPTION>
ITEM                                                                             PAGE
<S>                                                                                <C>
PROXY STATEMENT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1

MATTERS TO BE CONSIDERED AT ANNUAL MEETING . . . . . . . . . . . . . . . . . . . . .2

     PROPOSAL ONE -- ELECTION OF DIRECTORS . . . . . . . . . . . . . . . . . . . . .2

     PROPOSAL TWO -- AMENDMENT TO AND RESTATEMENT OF THE COMPANY'S RESTATED 
     CERTIFICATE OF INCORPORATION. . . . . . . . . . . . . . . . . . . . . . . . . .3

     PROPOSAL THREE -- APPROVAL OF AMENDMENTS TO 1992 STOCK OPTION/STOCK ISSUANCE
     PLAN. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5

     PROPOSAL FOUR -- RATIFICATION OF INDEPENDENT AUDITORS . . . . . . . . . . . . 11

     OTHER MATTERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

OWNERSHIP OF SECURITIES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

EXECUTIVE COMPENSATION AND RELATED INFORMATION . . . . . . . . . . . . . . . . . . 14

     Executive Compensation. . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

     Summary Compensation Table. . . . . . . . . . . . . . . . . . . . . . . . . . 14

     Option Grants in Last Fiscal Year . . . . . . . . . . . . . . . . . . . . . . 14

     Employment Contracts, Termination of Employment Arrangements and Change in
     Control Agreements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

     Ten-Year Option/SAR Repricings. . . . . . . . . . . . . . . . . . . . . . . . 16

CERTAIN TRANSACTIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

COMPENSATION COMMITTEE REPORT. . . . . . . . . . . . . . . . . . . . . . . . . . . 20

COMPARISON OF STOCKHOLDER RETURN . . . . . . . . . . . . . . . . . . . . . . . . . 20

COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934 . . . . . . . 21

STOCKHOLDER PROPOSALS FOR 1999 ANNUAL MEETING. . . . . . . . . . . . . . . . . . . 21

ANNUAL REPORT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

FORM 10-K/A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

EXHIBIT A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
</TABLE>

<PAGE>

                              CONDUCTUS, INC.

                              PROXY STATEMENT

                  FOR THE ANNUAL MEETING OF STOCKHOLDERS

                       TO BE HELD ON MAY 29, 1998

The enclosed proxy ("Proxy") is solicited on behalf of the Board of Directors 
of CONDUCTUS, INC., a Delaware corporation (the "Company"), for use at the 
1998 Annual Meeting of Stockholders to be held on May 29, 1998 (the "Annual 
Meeting"). The Annual Meeting will be held at 3:00 p.m. PST at the Company's 
administrative offices located at 965 West Maude Avenue, Sunnyvale, 
California 94086. These proxy solicitation materials were mailed on or about 
         , 1998, to all stockholders entitled to vote at the Annual Meeting.

VOTING

The specific proposals to be considered and acted upon at the Annual Meeting 
are summarized in the accompanying Notice of Annual Meeting of Stockholders 
and are described in more detail in this Proxy Statement. On April 16, 1998, 
the record date for determination of stockholders entitled to notice of and 
to vote at the Annual Meeting, 7,046,421 shares of the Company's common 
stock, $.0001 par value ("Common Stock"), were issued and outstanding. Each 
stockholder is entitled to one vote for each share of Common Stock held by 
such stockholder on April 16, 1998. Stockholders may not cumulate votes in 
the election of directors.

Directors are elected by a plurality vote of the affirmative votes cast by 
those shares present in person, or represented by proxy, and entitled to vote 
at the Annual Meeting.  The five nominees for director receiving the highest 
number of affirmative votes will be elected.  Abstentions and broker 
non-votes will not be counted toward a nominee's total.  Stockholders may not 
cumulate votes in the election of directors. Approval of the amendment to and 
restatement of the Company's Restated Certificate of Incorporation requires 
the affirmative vote of a majority of the Company's Common Stock issued and 
outstanding, and entitled to vote at the Annual Meeting. Abstentions and 
broker non-votes will be treated as votes against the proposal. Approval of 
amendments to the Company's 1992 Stock Option/Stock Issuance Plan requires 
the affirmative vote of a majority of those shares present in person or 
represented by proxy, and entitled to vote at the Annual Meeting.  
Abstentions will be treated as votes against the proposal. Broker non-votes 
will be treated as not entitled to vote on this matter and thus will have no 
effect on the outcome of the vote.  Ratification of the appointment of 
Coopers & Lybrand L.L.P. as the Company's independent public accountants for 
the fiscal year ending December 31, 1998, requires the affirmative vote of a 
majority of those shares present in person, or represented by proxy, and cast 
either affirmatively or negatively at the Annual Meeting.  Abstentions and 
broker non-votes will not be counted as having been voted on the proposal.

REVOCABILITY OF PROXIES

Whether or not you are able to attend the Company's Annual Meeting, you are 
urged to complete and return the enclosed proxy, which is solicited by the 
Company's Board of Directors and which will be voted as you direct on your 
proxy when properly completed. In the event no directions are specified, such 
proxies will be voted FOR the Nominees of the Board of Directors (as set 
forth in Proposal No. 1), FOR Proposals Nos. 2, 3 and 4 and in the discretion 
of the proxy holders as to other matters that may properly come before the 
Annual Meeting. You may revoke or change your Proxy at any time before the 
Annual Meeting by filing with the Secretary of the Company, at the Company's 
principal executive offices, a notice of revocation or another signed Proxy 
with a later date. You may also revoke your Proxy by attending the Annual 
Meeting and voting in person.

SOLICITATION

The Company will bear the entire cost of solicitation, including the 
preparation, assembly, printing and mailing of this Proxy Statement, the 
Proxy and any additional soliciting materials furnished to stockholders. 
Copies of solicitation materials will be furnished to brokerage houses, 
fiduciaries, and custodians holding shares in their names that are 
beneficially owned by others so that they may forward these solicitation 
materials to such beneficial owners. In addition, the Company may reimburse 
such persons for their costs in forwarding these solicitation materials to 
such beneficial owners. The original solicitation of proxies by mail may be 
supplemented by a solicitation by telephone, telegram, or other means by the 
Company's directors, officers or employees. No additional compensation will 
be paid to these individuals for any such services. Except as described 
above, the Company does not presently intend to solicit proxies other than by 
mail. 

<PAGE>

                               CONDUCTUS, INC.


                  MATTERS TO BE CONSIDERED AT ANNUAL MEETING

                    PROPOSAL ONE - ELECTION OF DIRECTORS

GENERAL

The Company currently has five directors. All directors hold office until the 
next annual meeting of stockholders or until their successors are duly 
elected and qualified. The officers serve at the discretion of the Board of 
Directors (the "Board").

The Board has selected five nominees, all of whom are currently serving as 
directors of the Company. The names of the persons who are nominees for 
director and their positions with the Company as of April 16, 1998 are set 
forth in the table below. Each person nominated for election has agreed to 
serve, if elected, and management has no reason to believe that any nominee 
will be unavailable to serve. In the event any nominee is unable or declines 
to serve as a director at the time of the Annual Meeting, the proxies will be 
voted for any nominee who may be designated by the present Board to fill the 
vacancy. Unless otherwise instructed, the proxy holders will vote the proxies 
received by them FOR the nominees named below. The five candidates receiving 
the highest number of affirmative votes of the shares represented and voting 
on this particular matter at the Annual Meeting will be elected directors of 
the Company, to serve their respective terms and until their successors have 
been elected and qualified.

    NOMINEES FOR TERM ENDING UPON THE 1999 ANNUAL STOCKHOLDERS' MEETING

   <TABLE>
   <CAPTION>
   Nominee                      Age        Positions and Offices Held with the Company
   -------                      ---        -------------------------------------------
   <S>                          <C>        <C>
   John F. Shoch, Ph.D(1)(2)    49         Chairman of the Board

   Charles  E. Shalvoy          50         President, Chief Executive Officer and Director

   Martin Cooper (1)            69         Director

   Robert M. Janowiak           61         Director

   Martin J. Kaplan (2)         60         Director
</TABLE>

(1) Member of the Audit Committee.

(2) Member of the Compensation Committee.

BUSINESS EXPERIENCE OF DIRECTORS

DR. SHOCH has served as Chairman of the Board of the Company since its 
inception in 1987. As a founder of Conductus, Dr. Shoch served as President 
from 1987 to 1988. Since 1985, he has been a general partner of AMC Partners 
84, which is the general partner of Asset Management Associates 1984, a 
venture capital investment fund and a principal stockholder of the Company. 
Dr. Shoch holds a B.S. in political science and an M.S. and Ph.D. in computer 
science from Stanford University.

MR. SHALVOY joined the Company in June 1994 as President, Chief Executive 
Officer and Director. From 1988 to 1994, he was President and Chief Operating 
Officer of Therma-Wave, Inc., a manufacturer of semiconductor production 
equipment. Prior to that he was employed by Aehr Test Systems and Raychem 
Corporation in a variety of senior management positions. Mr. Shalvoy holds a 
B.S. in Mechanical Engineering from the University of Notre Dame and a M.B.A. 
from Stanford University.

MR. COOPER has served as director of the Company since January 1995. Since 
1992, Mr. Cooper has served as Chairman and Chief Executive Officer of 
ArrayComm, Inc., a company he co-founded that manufactures intelligent 
antennas for wireless applications. Previously he was co-founder, Chairman, 
Chief Executive Officer and President of Cellular Business Systems, Inc., a 
provider of management information software to the cellular industry that was 
purchased by Cincinnati Bell in 1983. Mr. Cooper worked for 29 years at 
Motorola Inc., where he started out as a Senior Development Engineer in 1954 
and advanced to Corporate Director of Research and Development in 1983. Mr. 
Cooper earned a B.S. and M.S. in Electrical Engineering from the Illinois 
Institute of Technology.


                                     -2-
<PAGE>

                               CONDUCTUS, INC.


MR. JANOWIAK has served as Director of the Company since December 1996. Since 
1982, he has served as the Executive Director of the International 
Engineering Consortium. Prior to that, he was President of Federal Signal 
Corporation's Signal Group, a provider of public safety products and systems. 
Mr. Janowiak also held positions with ITT Research and Rockwell, where he 
advanced to Vice-President, General Manager of the Information Products 
Division.  Mr. Janowiak earned a B.S.E.E. from the University of Illinois, an 
M.S.E.E. from Illinois Institute of Technology and an M.B.A. from the 
University of Chicago.

MR. KAPLAN has served as Director of the Company since July 1996. Since 1997, 
Mr. Kaplan has served as an Executive Vice-President of Pacific Telesis 
Group. Prior to that he was President - Network Services Group of Pacific 
Bell, a Regional Bell Operating Company. Mr. Kaplan has worked for Pacific 
Bell and its successor, Pacific Telesis, for 38 years in various senior 
management positions. Mr. Kaplan earned a B.S. in engineering from California 
Institute of Technology.

There are no family relationships among executive officers or directors of 
the Company.

BOARD COMMITTEES AND MEETINGS

During the fiscal year ended December 31, 1997, the Board held five meetings. 
The Board has an Audit Committee and a Compensation Committee but does not 
have a nominating committee. Each of the directors attended or participated 
in 75% or more of the total meetings of the Board and of the committee(s) on 
which he served during the past fiscal year.

The Audit Committee currently consists of two directors, Dr. Shoch and Mr. 
Cooper, and is primarily responsible for approving the services performed by 
the Company's independent auditors and reviewing their reports regarding the 
Company's accounting practices and systems of internal accounting controls. 
The Audit Committee held two meetings during the last fiscal year.

The Compensation Committee currently consists of two directors, Dr. Shoch and 
Mr. Kaplan, and is primarily responsible for reviewing and approving the 
Company's general compensation policies and setting compensation levels for 
the Company's executive officers. The Compensation Committee also has the 
authority to administer the Company's 1992 Stock Option/Stock Issuance Plan, 
as amended, and make option grants thereunder. The Compensation Committee 
held two meetings during the last fiscal year.

DIRECTOR COMPENSATION

Directors receive no cash compensation for serving on the Board.  In January 
1995, several non-employee directors were granted options, under the 
Automatic Option Grant Program of the Company's 1992 Stock Option/Stock 
Issuance Plan, as follows: Mr. Cooper - 15,000 shares and Dr. Shoch - 15,000 
shares. Each new Option was granted at an exercise price of $4.93 per share. 
In July 1996, Mr. Kaplan was granted a non-qualified stock option to purchase 
15,000 shares of Common Stock at an exercise price of $11.25 per share under 
the Automatic Grant Program. This option was canceled in November 1997 in 
exchange for a new option to purchase 15,000 shares of Common Stock at a 
purchase price of $6.50. In November 1996, Mr. Janowiak was granted a 
non-qualified stock option to purchase 15,000 shares of Common Stock at an 
exercise price of $ 6.56 per share under the Automatic Grant Program. In 
October 1996 each non-employee director was granted options to purchase 3,000 
shares of Common stock at an exercise price of $8.00 under the Automatic 
Option Grant Program. In May 1997, Mr. Cooper, Mr. Janowiak, Mr. Kaplan and 
Dr. Shoch were each granted options to purchase 3,000 shares of Common Stock 
at an exercise price of $7.125 under the Automatic Option Grant Program.  If 
Proposal Two is approved by the stockholders, directors (including 
non-employee directors) will also be eligible for discretionary option grants 
under the Company's 1992 Stock Option/Stock Issuance Plan. Except for the 
foregoing option grants and for reimbursement of certain expenses in 
connection with attendance at Board and committee meetings, directors receive 
no compensation for attending meetings of the Board of Directors.

THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE ELECTION 
OF EACH OF THE ABOVE NOMINEES.

           PROPOSAL TWO -- AMENDMENT TO AND RESTATEMENT OF THE
            COMPANY'S RESTATED CERTIFICATE OF INCORPORATION

The Board of Directors has determined that it is in the best interests of the 
Company and its stockholders to amend and restate the Company's Restated 
Certificate of Incorporation to increase the number of authorized shares of 
Common Stock 

                                   -3-

<PAGE>

of the Company from 11,000,000 to 20,000,000 shares and to increase the 
number of authorized shares of Preferred Stock of the Company from 1,000,000 
to 5,000,000 shares. Accordingly, the Board of Directors has unanimously 
approved the proposed Amended and Restated Certificate of Incorporation, in 
substantially the form attached hereto as Exhibit A (the "Restated 
Certificate"), and hereby solicits the approval of the Company's stockholders 
of the Restated Certificate. If the stockholders approve the Restated 
Certificate, the Board of Directors currently intends to file the Restated 
Certificate with the Secretary of State of the State of Delaware as soon as 
practicable following such stockholder approval. If the Restated Certificate 
is not approved by the stockholders, the existing Certificate of 
Incorporation will continue in effect.

The objectives of the increases in the authorized number of shares of Common 
Stock and Preferred Stock are to ensure that the Company has sufficient 
shares available for future equity issuances. The Board of Directors believes 
that it is prudent to increase the authorized number of shares of Common 
Stock and Preferred Stock to the proposed levels in order to provide a 
reserve of shares available for issuance to meet business needs as they 
arise. Such future activities may include, without limitation, financings, 
establishing strategic relationships with corporate partners, providing 
equity incentives to employees, officers or directors, or effecting stock 
splits or dividends. The Company has retained a financial advisor to seek to 
raise up to $8 million in gross proceeds (before offering commissions and 
expenses) to fund its working capital and other requirements. Although the 
terms of the proposed offering have not been finalized, the Company 
currently plans to issue shares of its Preferred Stock in the offering. The 
proposed terms of the Preferred Stock have not been determined. There can be 
no assurance that the offering can be completed or, if it is, as to the 
amount of gross proceeds that the Company will raise or the type or terms of 
the securities that will be issued by the Company. Failure to amend and 
restate the Company's Restated Certificate of Incorporation will have a 
material adverse effect on the ability of the Company to complete the 
offering which, in turn, will have a material adverse effect on the Company. 

The additional shares of Common Stock or Preferred Stock authorized may also 
be used to acquire or invest in complementary businesses or products or to 
obtain the right to use complementary technologies. Although the Company has 
no present obligation to issue additional shares of Common Stock or Preferred 
Stock (except pursuant to stock option/stock issuance plans, the Employee 
Stock Purchase Plan and existing warrants), the Company may continue to 
evaluate potential acquisitions of or investments with third parties. 
However, the Company currently has no specific plans to enter into any such 
transaction.

POSSIBLE EFFECTS OF THE PROPOSED AMENDMENT TO AND RESTATEMENT OF THE 
CERTIFICATE OF INCORPORATION

If the stockholders approve the proposed Restated Certificate, the Board of 
Directors may cause the issuance of additional shares of Common Stock or 
Preferred Stock without further vote of the stockholders of the Company, 
except as provided under Delaware corporate law or under the rules of any 
securities exchange on which shares of Common Stock and Preferred Stock of 
the Company are then listed. Current holders of Common Stock have no 
preemptive or similar rights, which means that current stockholders do not 
have a prior right to purchase any new issue of capital stock of the Company 
in order to maintain their appropriate ownership thereof. The issuance of 
additional shares of Common Stock or Preferred Stock would decrease the 
proportionate equity interest of the Company's current stockholders and, 
depending upon the price paid for such additional shares, could result in 
dilution to the Company's current stockholders.

In addition, as is presently the case, the Board of Directors could use 
authorized but unissued shares to create impediments to a takeover or a 
transfer of control of the Company. For example, the Board of Directors has 
created 50,000 shares of Series A Preferred shares which are available for 
issuance pursuant to the Company's Shareholders' Rights Plan dated January 
29, 1998. In addition, the Board of Directors has the authority to issue the 
Preferred Stock in one or more series and to fix the rights, preferences, 
privileges and restrictions thereof, including dividend rights, dividend 
rates, conversion rights, voting rights, terms of redemption, redemption 
prices, liquidation preferences and the number of shares constituting any 
series or the designation of such series, without further vote or action by 
the stockholders. The issuance of Preferred Stock pursuant to the Shareholder 
Rights Plan and the [ILLEGIBLE COPY] other Preferred Stock authorized by the 
Board of Directors may have the effect of delaying, deferring or preventing a 
change in control of the Company without further action by the stockholders 
and may adversely affect the voting and other rights of the holders of Common 
Stock. The issuance of preferred Stock with voting and conversion rights may 
adversely affect the voting power of the holders of Common Stock, including 
the loss of voting control to others. At present, the Company has no plans to 
issue any of the Preferred Stock.

                                   -4-

<PAGE>

THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR APPROVAL OF 
THE AMENDMENT TO AND RESTATEMENT OF THE COMPANY'S RESTATED CERTIFICATE OF 
INCORPORATION.


           PROPOSAL THREE -- APPROVAL OF AMENDMENTS TO 1992 STOCK
                       OPTION/STOCK ISSUANCE PLAN

Stockholders are being asked to vote on a proposal to approve amendments to 
the Company's 1992 Stock Option/Stock Issuance Plan (the "Plan") to (a) 
modify the maximum number of stock options and direct stock issuances that 
may be granted to a single employee from 240,000 shares over the life of the 
Plan to 750,000 shares in a single calendar year and (b) permit discretionary 
option grants to your non-employee directors. The Board deems it advisable to 
modify the limitation on the maximum number of shares of Common Stock which 
may be awarded to a single individual under the Plan in order to allow the 
Company to use its equity incentives to attract and retain the services of 
key individuals essential to the Company's long term success. The original 
limitation was adopted in anticipation of the adoption of regulations 
defining the requirements for satisfying the requirements of section 162(m) 
of the Internal Revenue Code of 1986. The amended limitation satisfies the 
requirements of the regulations, as adopted, and thus of section 162(m) of 
the Internal Revenue Code of 1986. The Board also deems it advisable to 
eliminate the Plan's prohibition against discretionary option grants to 
non-employee directors. The prohibition originally was required by Rule 16b-3 
of the Securities and Exchange Commission, but Rule 16b-3 has been amended to 
permit discretionary grants.  Since directors receive no cash compensation 
from the Company, this amendment will facilitate the attraction and retention 
of qualified directors.

The following is a summary of the principal features of the Plan. The 
summary, however, does not purport to be a complete description of all the 
provisions of the Plan. Any stockholder of the Company who wishes to obtain a 
copy of the actual plan document may do so by written request to the 
Corporate Secretary at the Company's principal executive offices.

EQUITY INCENTIVE PROGRAMS

The Plan includes three separate equity incentive programs: (i) a 
Discretionary Option Grant Program, under which eligible individuals may be 
granted options to purchase shares of Common Stock, (ii) an Automatic Option 
Grant Program under which non-employee Board members are automatically 
granted options to purchase shares of Common Stock, and (iii) a Stock 
Issuance Program, under which eligible individuals may be issued shares of 
Common Stock directly, through the immediate purchase of the shares or as a 
bonus tied to the performance of services or the Company's attainment of 
financial objectives.

Options granted under the Discretionary Option Grant Program may be either 
incentive stock options designed to meet the requirements of Section 422 of 
the Internal Revenue Code or non-statutory options not intended to satisfy 
such requirements.

SHARE RESERVE

2,080,000 shares of Common Stock have been reserved for issuance over the ten 
(10) year term of the Plan.

The issuable shares may be made available from either the Company's 
authorized but unissued shares of Common Stock or from re-acquired shares of 
Common Stock, including shares repurchased by the Company on the open market. 
Should an option (including outstanding options incorporated into the Plan 
from predecessor plans) expire or terminate for any reason prior to exercise 
in full (including options canceled in accordance with the 
cancellation/regrant provisions of the Plan), the shares subject to the 
portion of the option not so exercised will be available for subsequent 
issuance under the Plan. Shares subject to any option surrendered in 
accordance with the stock appreciation right provisions of the Plan and all 
share issuances under the Plan, whether or not the shares are subsequently 
re-acquired by the Company pursuant to its repurchase rights under the Plan, 
will reduce on a share-for-share basis the number of shares of Common Stock 
available for subsequent issuance.

No individual participating in the Plan may be granted stock options and 
direct stock issuances for more than 240,000 shares of Common Stock in the 
aggregate over the remaining term of the Plan. Options granted prior to 
January 1, 1994, will not be taken into account for purposes of determining 
the 240,000 share limit. Subject to approval of Proposal Three, this 
limitation will be increased to 750,000 shares in any single calendar year.



                                     -5-
<PAGE>

                               CONDUCTUS, INC.


As of April 16, 1998, options covering 1,006,237 shares were outstanding 
under the Plan and 509,939 shares remained available for future option 
grants. The expiration dates for all such options range from October 26, 2000 
to March 2, 2008. 

PLAN ADMINISTRATION

The Plan is administered by a committee (the "Committee") comprised of two or 
more non-employee Board members appointed by the Board. The Committee has 
discretion (subject to the provisions of the Plan) to authorize stock option 
grants and direct stock issuances. 

ELIGIBILITY

Officers, directors, other employees and independent consultants and advisors 
to the Company (or any parent or subsidiary company) will be eligible to 
participate in the Plan. 

As of April 16, 1998, it was estimated that five executive officers, four 
outside directors and 68 other employees were eligible to participate in the 
Plan.

VALUATION

The fair market value per share of Common Stock on any relevant date under 
the Plan will be the closing selling price per share on that date on the 
Nasdaq Stock Market. If there is no reported selling price for such date, 
then the closing selling price for the last previous date for which such 
quotation exists will be determinative of fair market value. The fair market 
value of Common Stock on April 16, 1998, as reported on the Nasdaq Stock 
Market, was $3.8125 per share.

DISCRETIONARY OPTION GRANT PROGRAM

Under the Discretionary Option Grant Program, the exercise price per share of 
Common Stock subject to an incentive stock option will not be less than 100% 
of the fair market value per share on the grant date. The exercise price per 
share of the Common Stock subject to a non-statutory option may not be less 
than 85% of such fair market value on the grant date. No option will have a 
maximum term in excess of ten years measured from the grant date. The 
Committee has discretion to grant options (i) which are immediately 
exercisable for vested shares, (ii) which are immediately exercisable for 
unvested shares subject to the Company's repurchase rights or (iii) which 
become exercisable in installments for vested shares over the optionee's 
period of service.

The exercise price may be paid in cash or in shares of Common Stock valued at 
fair market value on the exercise date. The option may also be exercised for 
vested shares through a same-day sale program pursuant to which the purchased 
shares are to be sold immediately and a portion of the sale proceeds is to be 
applied to the payment of the exercise price for those shares on the 
settlement date.

Any option held by the optionee at the time of cessation of service will 
normally not remain exercisable beyond the limited period designated by the 
Committee at the time of the option grant. During that period, the option 
will generally be exercisable only for the number of shares in which the 
optionee is vested at the time of cessation of service. For purposes of the 
Plan, an individual will (except to the extent otherwise specifically 
provided in the Option or Issuance Agreement) be deemed to continue in 
service for so long as that person performs services on a periodic basis for 
the Company or any parent or subsidiary corporations, whether as an employee, 
a non-employee member of the Board or an independent consultant or advisor. 
The Committee may extend the period following the optionee's cessation of 
service during which his or her outstanding options may be exercised and/or 
accelerate the exercisability of such options in whole or in part. Such 
discretion may be exercised at any time while the options remain outstanding.

Any unvested shares of Common Stock will be subject to repurchase by the 
Company, at the original exercise price paid per share, upon the optionee's 
cessation of service prior to vesting in these shares. The Committee will 
have complete discretion in establishing the vesting schedule for any such 
unvested shares and will have full authority to cancel the Company's 
outstanding repurchase rights with respect to these shares in whole or in 
part at any time.

The optionee is not to have any stockholder rights with respect to the option 
shares until the option is exercised and the exercise price is paid for the 
purchased shares. Options are not assignable or transferable other than by 
will or by the laws of inheritance following the optionee's death, and the 
option may, during the optionee's lifetime, be exercised only by the optionee.

                                     -6-
<PAGE>

                               CONDUCTUS, INC.


One or more officers of the Company may be granted limited stock appreciation 
rights in connection with their option grants. Any option with such a limited 
stock appreciation right in effect for at least six months will automatically 
be canceled, to the extent such option is at the time exercisable for fully 
vested shares, upon the successful completion of a hostile tender offer for 
securities possessing 50% or more of the combined voting power of the 
Company's outstanding securities. In return for the canceled option, the 
officer will be entitled to a cash distribution from the Company in an amount 
per vested share of Common Stock subject to the canceled option equal to the 
excess of (i) the price per share of Common Stock paid in such hostile tender 
offer over (ii) the option exercise price.

The Committee will have the authority to effect, on one or more separate 
occasions, the cancellation of outstanding options under the Discretionary 
Option Grant Program (including outstanding options incorporated from the 
predecessor plans) which have exercise prices in excess of the then current 
market price of Common Stock and to issue replacement options with an 
exercise price based on the market price of Common Stock at the time of the 
new grant.

AUTOMATIC OPTION GRANT PROGRAM

The Automatic Option Grant Program under the Option Plan provides for the 
grant of non-statutory options to purchase shares of Common Stock to 
non-employee Board members. Each non-employee Board member who first becomes 
a non-employee Board member at any time on or after January 23, 1995, will 
automatically be granted at the time of such initial election or appointment 
an option to purchase 15,000 shares of Common Stock. In addition, four 
non-employee Board members received an option to purchase 15,000 shares of 
Common Stock on January 23, 1995. Two non-employee Board members received 
options for 15,000 shares of Common Stock upon joining the Board in 1996. 

Additionally, each individual who served as a non-employee Board member on 
October 24, 1996, and had served in that capacity for the immediately 
preceding ninety (90) days automatically received an option to purchase three 
thousand (3,000) shares of Common Stock ("Annual Automatic Option Grant") on 
that date. Thereafter, each Outside Director who has served in that capacity 
for the immediately preceding ninety (90) days and continues to so serve, 
will receive as an Annual Automatic Option Grant an option to purchase three 
thousand (3,000) shares of Common Stock at the Annual Shareholder Meeting.

The option price per share for each automatic grant will be the fair market 
value per share of Common Stock on the date of grant. The option prices for 
purchased shares will be payable in cash or shares of Common Stock held for 
at least six months, or through a same-day sale program.

Automatic option grants have a term of ten (10) years from the date of grant 
and will be immediately exercisable. However, the Company will have 
repurchase rights with respect to the nonvested shares purchased under the 
options. In the case of a director's initial grant, 20% of the shares vest 
one year after the date of grant, and the remaining shares vest in 48 equal 
monthly installments over the following four years.  In the case of the 
annual grants, 33.3% of the shares vest one year after the date of grant, and 
the remaining shares vest in 24 equal monthly installments over the following 
two years.

If the optionee ceases to serve as a Board member, the option may be 
exercised to the extent then exercisable and within its term for a period of 
three months after the date of cessation (12 months if due to disability, and 
three years if due to death). In the case of death, the option may be 
exercised within such period by the estate or heirs of the optionee.

In the event of any Corporate Transaction, as defined below, each outstanding 
option shall automatically vest in full so that each such option shall, 
immediately prior to the specified effective date for the Corporate 
Transaction, be exercisable for all or any portion of such shares as 
fully-vested shares of Common Stock. Immediately following the consummation 
of the Corporate Transaction, each Automatic Option Grant under the Plan 
shall terminate and cease to be outstanding, except to the extent assumed by 
the successor corporation or its parent company.

In connection with any Change in Control of the Company, as defined below, 
each outstanding option shall automatically vest in full so that each such 
option shall immediately prior to the specified effective date for the Change 
in Control be exercisable for all or any portion of such shares as 
fully-vested shares of Common Stock. Each such option shall remain fully 
exercisable until the expiration or sooner termination of the option term or 
the cash-out of the option pursuant to a Hostile Take-Over.

Upon the occurrence of a Hostile Take-Over, the optionee shall have a thirty 
(30)-day period in which to surrender 

                                     -7-
<PAGE>

                               CONDUCTUS, INC.


to the Company each Automatic Option Grant held by him or her under this Plan 
for a period of at least six months. The optionee shall in return be entitled 
to a cash distribution from the Company in an amount equal to the excess of 
(i) the Take-Over Price of the shares of Common Stock at the time subject to 
the surrendered option (whether or not the optionee is otherwise at the time 
vested in those shares) over (ii) the aggregate exercise price payable for 
such shares. Such cash distribution shall be paid within five days following 
the surrender of the option to the Company. No approval or consent of the 
Board shall be required in connection with such option surrender and cash 
distribution.

STOCK ISSUANCE PROGRAM

Shares may be sold under the Stock Issuance Program at a price per share not 
less than 85% of fair market value, payable in cash or through a promissory 
note payable to the Company, or as a bonus for past services. Shares issued 
under the Stock Issuance Program may either be vested upon issuance or 
subject to a vesting schedule tied to the participant's period of service or 
the attainment of designated performance goals. Unvested shares will be 
subject to certain transfer restrictions and to repurchase or cancellation by 
the Company upon either the participant's cessation of service prior to 
vesting in those shares or the non-attainment of the applicable performance 
goals. The Committee has discretion to accelerate the vesting of any issued 
shares in whole or in part at any time. Individuals holding shares under the 
Stock Issuance Program will have full stockholder rights with respect to 
those shares, whether the shares are vested or unvested.

                               GENERAL PROVISIONS

OPTION/VESTING ACCELERATION

Outstanding options under the Plan may become immediately exercisable in 
full, and unvested shares issued under the Plan may become fully vested, in 
the event of certain changes in the ownership or control of the Company. The 
transactions which may trigger such option/vesting acceleration are as 
follows:

CORPORATE TRANSACTION: any one of the following stockholder approved 
transactions (a "Corporate Transaction"):

1.       a merger or consolidation in which the Company is not the surviving 
         entity, except for a transaction the principal purpose of which is 
         to change the State of the Company's incorporation;

2.       the sale, transfer or other disposition of all or substantially all 
         of the assets of the Company in liquidation or dissolution of the 
         Company; or

3.       any reverse merger in which the Company is the surviving entity but 
         in which securities possessing more than fifty percent (50%) of the 
         total combined voting power of the Company's outstanding securities 
         are transferred to holders different from those who held such 
         securities immediately prior to the merger.

CHANGE IN CONTROL: a change in ownership or control of the Company effected
through either of the following transactions (a "Change in Control"): 

1.       any person or related group of persons (other than the Company or a 
         person that directly or indirectly controls, is controlled by, or is 
         under common control with, the Company) directly or indirectly 
         acquires beneficial ownership within the meaning of Rule 13d-3 of the
         Securities Exchange Act of 1934, as amended (the "Act") of securities
         possessing more than fifty percent (50%) of the total combined voting
         power of the Company's outstanding securities pursuant to a tender or
         exchange offer made directly to the Company's stockholders which the 
         Board does not recommend such stockholders to accept; or

2.       a change in the composition of the Board over a period of twenty-
         four (24) consecutive months or less such that a majority of the Board
         members (rounded up to the next whole number) ceases, by reason of one
         or more proxy contests for the election of Board members, to be 
         comprised of individuals who either (i) have been Board members 
         continuously since the beginning of such period or (ii) have been 
         elected or nominated for election as Board members during such period
         by at least a majority of the Board members described in clause 
         (i) who were still in office at the time such election or nomination 
         was approved by the Board.

Following a Corporate Transaction, all outstanding options become exercisable 
in full, except that options generally do not accelerate if they are assumed 
by the successor corporation, if the successor corporation substitutes 
comparable options to purchase its own stock, or if the successor corporation 
substitutes a comparable cash incentive program based on the option spread at 
the time of the Corporate Transaction.  Upon the consummation of the 
Corporate Transaction, all outstanding options will terminate if they are not 
assumed by the successor corporation.  In addition, in the event of a 

                                     -8-
<PAGE>

                               CONDUCTUS, INC.


Corporate Transaction, all shares that remain subject to the Company's right 
of repurchase will vest in full, except that vesting generally does not 
accelerate if the repurchase right is assigned to the successor corporation.

In the event of a Change in Control, the Committee, at its discretion, may 
accelerate any outstanding options and vest any shares that remain subject to 
the Company's right of repurchase.  The Committee may also determine that the 
acceleration will occur only if the optionee's service terminates within a 
specified period after the Change in Control.

The acceleration of options or vesting of shares in the event of a Corporate 
Transaction or Change in Control may be seen as an anti-takeover provision 
and may have the effect of discouraging a merger proposal, a takeover attempt 
or other efforts to gain control of the Company.

HOSTILE TAKE-OVERS

One or more officers of the Company may, in the Plan Administrator's sole 
discretion, be granted limited stock appreciation rights in connection with 
their outstanding options under the Plan. Upon the occurrence of a Hostile 
Take-Over, each outstanding option with such a limited stock appreciation 
right in effect for at least six months shall automatically be canceled, to 
the extent such option is at the time exercisable for fully-vested shares of 
Common Stock. The Optionee shall in return be entitled to a cash distribution 
from the Company in an amount equal to the excess of (i) the Take-Over Price 
of the vested shares of Common Stock at the time subject to the canceled 
option (or canceled portion of such option) over (ii) the aggregate exercise 
price payable for such shares. Neither the approval of the Committee nor the 
consent of the Board shall be required in connection with such option 
cancellation and cash distribution.

A Hostile Take-Over shall be deemed to occur in the event (i) any person or 
related group of persons (other than the Company or a person that directly or 
indirectly controls, is controlled by, or is under common control with the 
Company) directly or indirectly acquires beneficial ownership, within the 
meaning of Rule 13d-3 of the 1934 Act, of securities possessing more than 50% 
of the total combined voting power of the Company's outstanding securities 
pursuant to a tender or exchange offer made directly to the Company's 
stockholders which the Board does not recommend such stockholders to accept 
and (ii) more than 50% of the securities so acquired in such tender or 
exchange offer are accepted from holders other than officers and directors of 
the Company subject to the short-swing profit restrictions of Section 16 of 
the 1934 Act.

The Take-Over Price per share shall be deemed to be equal to the greater of 
(a) the fair market value per share on the date of cancellation, as 
determined pursuant to the regular valuation provisions of the Plan, or 
(b) the highest reported price per share paid in effecting such Hostile 
Take-Over. However, if the canceled option is an Incentive Option, the 
Take-Over Price shall not exceed the clause (a) price per share.

CHANGES IN CAPITALIZATION

In the event any change is made to the Common Stock issuable under the Plan 
by reason of any stock split, stock dividend, recapitalization, combination 
of shares, exchange of shares or other change affecting the outstanding 
Common Stock as a class without the Company's receipt of consideration, then 
appropriate adjustments shall be made to (i) the number and/or class of 
shares issuable under the Plan, (ii) the number and/or class of shares and 
price per share in effect under each outstanding option under the Plan, 
(iii) the number and/or class of shares for which any one individual may be 
granted stock options and direct share issuances in the aggregate, (iv) the 
number and/or class of shares and price per share in effect under each 
outstanding option incorporated into this Plan from the predecessor plans and 
(v) the number and/or class of shares for which non-employee members of the 
Board receive options under the Automatic Option Grant Program.

FINANCIAL ASSISTANCE

The Committee may institute a loan program in order to assist one or more 
optionees in financing their exercise of outstanding options under the 
Discretionary Option Grant Program or the purchase of shares under the Stock 
Issuance Program. The form in which such assistance is to be made available 
(including loans or installment payments) and the terms upon which such 
assistance is to be provided will be determined by the Committee. However, 
the maximum amount of financing provided any participant may not exceed the 
amount of cash consideration payable for the issued shares plus all 
applicable Federal, State and local income and employment taxes 

                                     -9-
<PAGE>

                               CONDUCTUS, INC.


incurred in connection with the acquisition of the shares. Any such financing 
may be subject to forgiveness in whole or in part, at the discretion of the 
Committee, over the participant's period of service.

PREDECESSOR PLANS

Each stock option issued and outstanding under the predecessor plans 
immediately prior to the effective date of this Plan was incorporated into 
the Plan and treated as an outstanding stock option under the Plan, but each 
such option continues to be governed solely by the terms and conditions of 
the instrument evidencing such grant, and nothing in the Plan will be deemed 
to affect or otherwise modify the rights or obligations of the holders of 
such options with respect to their acquisition of shares thereunder. However, 
the Committee has discretion to extend one or more features of the Plan, 
including the various acceleration provisions, to any or all of the options 
incorporated from the predecessor plans.

AMENDMENT AND TERMINATION

The Board may amend or modify the Plan in any or all respects whatsoever. 
However, no such amendment may adversely affect the rights of existing 
optionees or holders of unvested shares without their consent. In addition, 
the Board may not without the approval of the Company's stockholders (i) 
materially increase the maximum number of shares issuable under the Plan or 
the maximum number of shares for which any one individual may be granted 
options or direct stock issuances, except to reflect certain changes in the 
Company's capital structure, or (ii) materially modify the eligibility 
requirements for option grants or share issuances.

The Board may terminate the Plan at any time, and the Plan will in all events 
terminate on January 10, 2002. Each stock option or unvested share issuance 
outstanding at the time of such termination will remain in force in 
accordance with the provisions of the instruments evidencing such grant or 
issuance.

                  FEDERAL INCOME TAX CONSEQUENCES

OPTION GRANTS

Options granted under the Plan may be either incentive stock options which 
satisfy the requirements of Section 422 of the Internal Revenue Code or 
non-statutory options which are not intended to meet such requirements. The 
Federal income tax treatment for the two types of options differs as 
described below:

INCENTIVE STOCK OPTIONS. No taxable income is recognized by the optionee at 
the time of the option grant, and no taxable income is generally recognized 
at the time the option is exercised. However, the difference between the fair 
market value of the purchased shares and the exercise price is generally 
included as alternative minimum taxable income for purposes of the 
alternative minimum tax. The optionee will recognize taxable income in the 
year in which the purchased shares are sold or otherwise made the subject of 
disposition. For Federal tax purposes, dispositions are divided into two 
categories: (i) qualifying and (ii) disqualifying. The optionee will make a 
qualifying disposition of the purchased shares if the sale or other 
disposition of such shares is made after the optionee has held the shares for 
more than two years after the grant date of the option and more than one year 
after the exercise date. If the optionee fails to satisfy either of these two 
minimum holding periods prior to the sale or other disposition of the 
purchased shares, then a disqualifying disposition will result.

Upon a qualifying disposition of the shares, the optionee will recognize 
capital gain in an amount equal to the excess of (i) the amount realized upon 
the sale or other disposition of the purchased shares over (ii) the exercise 
price paid for such shares. If there is a disqualifying disposition of the 
shares, then generally the excess of (i) the fair market value of those 
shares on the exercise date over (ii) the exercise price paid for the shares 
will be taxable as ordinary income. Any additional gain recognized upon the 
disposition will be a capital gain.

If the optionee makes a disqualifying disposition of the purchased shares, 
then the Company will generally be entitled to an income tax deduction, for 
the taxable year in which such disposition occurs, equal to the amount of 
ordinary income recognized by the optionee. In no other instance will the 
Company be allowed a deduction with respect to the optionee's disposition of 
the purchased shares.

NON-STATUTORY OPTIONS. No taxable income is recognized by an optionee upon 
the grant of a non-statutory option. The optionee will in general recognize 
ordinary income, in the year in which the option is exercised, equal to the 
excess of the fair market value of the purchased shares on the exercise date 
over the exercise price paid for the shares, and the optionee (if an employee 
or former employee) will be required to satisfy the tax withholding 
requirements applicable to such income.

                                     -10-
<PAGE>

                               CONDUCTUS, INC.


Special provisions of the Internal Revenue Code apply to the acquisition of 
unvested shares of Common Stock under a non-statutory option. These special 
provisions may be summarized as follows:

- -    If the shares acquired upon exercise of the non-statutory option are 
     subject to repurchase by the Company at the original exercise price in 
     the event of the optionee's termination of service prior to vesting in 
     those shares, then the optionee will not recognize any taxable income at 
     the time of exercise but will have to report as ordinary income, as and 
     when the Company's repurchase right lapses, an amount equal to the 
     excess of (i) the fair market value of the shares on the date the 
     repurchase right lapses with respect to those shares over (ii) the 
     exercise price paid for the shares.

- -    The optionee may, however, elect under Section 83(b) of the Internal 
     Revenue Code to include as ordinary income in the year of exercise of 
     the non-statutory option an amount equal to the excess of (i) the fair 
     market value of the purchased shares on the exercise date over (ii) the 
     exercise price paid for such shares. If the Section 83(b) election is 
     made, the optionee will not recognize any additional income as and when 
     the repurchase right lapses.

The Company will generally be entitled to a business expense deduction equal 
to the amount of ordinary income recognized by the optionee with respect to 
the exercised non-statutory option. The deduction will be allowed for the 
taxable year of the Company in which such ordinary income is recognized by 
the optionee. 

STOCK APPRECIATION RIGHTS

An optionee who is granted a stock appreciation right will recognize ordinary 
income in the year of exercise equal to the amount of the appreciation 
distribution. The Company will be entitled to a business expense deduction 
equal to the appreciation distribution for the taxable year in which the 
ordinary income is recognized by the optionee.

DIRECT STOCK ISSUANCES

The tax principles applicable to direct stock issuances under the Plan will 
be substantially the same as those summarized above for the exercise of 
non-statutory option grants.

PARACHUTE PAYMENTS.

If the exercisability of an option or stock appreciation right is accelerated 
as a result of a Change of Control, all or a portion of the value of the 
option or stock appreciation right at that time may be a parachute payment 
for purposes of the excess parachute provisions of the Internal Revenue Code. 
Those provisions generally provide that if parachute payments equal or exceed 
three times an employee's average annual compensation for the five tax years 
preceding the change of control, the Company loses its deduction and the 
recipient is subject to a 20% excise tax for the amount of the parachute 
payments in excess of one times such average compensation.

NEW PLAN BENEFITS

Awards under the Plan are discretionary, except for the Automatic Option 
Grant Program described above.  Therefore, it is not possible to determine 
the benefits that will be received in the future by participants in the Plan 
or the benefits that would have been received by such participants if the 
Plan, as amended, had been in effect in 1997.  New options for 60,000 shares 
and an additional 240,000 shares granted on April 13, 1998 in exchange for 
cancellation of prior grants to Charles E. Shalvoy under the Plan are subject 
to the approval of Proposal Three by the stockholders at the Annual Meeting.

THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE APPROVAL 
OF THE AMENDMENTS TO THE PLAN.

           PROPOSAL FOUR - RATIFICATION OF INDEPENDENT AUDITORS

The Board of Directors has appointed the firm of Coopers & Lybrand, L.L.P., 
independent public auditors for the Company during fiscal year 1997, to serve 
in the same capacity for the fiscal year ending December 31, 1998, and is 
asking the stockholders to ratify this appointment. 

In the event the stockholders fail to ratify the appointment, the Board will 
reconsider its selection. Even if 

                                     -11-
<PAGE>

                               CONDUCTUS, INC.


the selection is ratified, the Board in its discretion may direct the 
appointment of a different independent auditing firm at any time during the 
year if the Board believes that such a change would be in the best interests 
of the Company and its stockholders.

A representative of Coopers & Lybrand L.L.P. is expected to be present at the 
Annual Meeting and will have the opportunity to make a statement if he or she 
so desires. Such representative will be available to respond to appropriate 
questions.

THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE RATIFICATION OF THE 
SELECTION OF COOPERS & LYBRAND L.L.P. TO SERVE AS THE COMPANY'S INDEPENDENT 
AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 1998.

                               OTHER MATTERS

No other matters will be presented for consideration at the Annual Meeting.

                          OWNERSHIP OF SECURITIES

The following table sets forth certain information known to the Company with 
respect to the beneficial ownership of the Company's Common Stock as of April 
16, 1998 by (i) all persons who are beneficial owners of 5% or more of the 
outstanding shares of the Company's Common Stock, (ii) each director and 
nominee, (iii) the Company's Chief Executive Officer and each of the three 
other most highly paid current executive officers and (iv) all current 
directors and executive officers as a group.

<TABLE>
<CAPTION>
5% STOCKHOLDERS, DIRECTORS, EXECUTIVE OFFICERS &      SHARES BENEFICIALLY       PERCENT BENEFICIALLY
  DIRECTORS AND EXECUTIVE OFFICERS AS A GROUP              OWNED (1)                 OWNED (2)
  -------------------------------------------              ---------                 ---------
<S>                                                         <C>                        <C>
Charles L. Grimes                                           620,000                    8.9%
P.O. Box 136
Mendenhall, PA 19357-0136

Hewlett-Packard Company ("H-P")                             558,212                    8.0%
3000 Hanover Street
Palo Alto, CA 94304

Portola Group                                               455,445                    6.5%
3000 Sand Hill Road
Bldg. 2-145
Menlo Park, CA 94025

Asset Management 1984 (3)                                   351,581                    5.1%
2275 East Bayshore Road
Suite 150
Palo Alto, CA 94303

John F. Shoch (4)                                           386,393                    5.5%

Martin Cooper (5)                                            21,000                    *

Robert Janowiak (6)                                          18,000                    *

Martin Kaplan (7)                                            22,500                    *

Charles E. Shalvoy (8)                                      257,486                    3.6%

William J. Fowler (9)                                        15,384                    *

Graham Y. Mostyn (10)                                        15,384                    *

Randy W. Simon (11)                                          70,135                    *

All directors and executive officers
as a group (9 persons) (12)                                 843,484                   11.3%
- --------------------------------------------------------------------------------------------------
</TABLE>



                                     -12-
<PAGE>

                               CONDUCTUS, INC.


Notes

*Less than 1%

(1)  Beneficial ownership is determined in accordance with the rules of the 
Securities and Exchange Commission and generally includes sole or shared 
voting or investment power with respect to securities. Shares of Common Stock 
subject to options or warrants currently exercisable or convertible, or 
exercisable or convertible within 60 days of April 16, 1998, are deemed 
outstanding for purposes of computing the percentage ownership of the person 
holding such option or warrant but are not outstanding for purposes of 
computing the percentage of any other person. Except as indicated in the 
footnotes to this table and pursuant to applicable community property laws, 
the persons named in the table have sole voting and investment power with 
respect to all shares of Common Stock beneficially owned.

(2)  Percentage of beneficial ownership is calculated assuming 7,046,421 
shares of Common Stock were outstanding on April 16, 1998.  This percentage 
also includes Common Stock of which such individual or entity has the right 
to acquire beneficial ownership within sixty days of April 16, 1998, 
including, but not limited to, the exercise of an option; however, such 
Common Stock shall not be deemed outstanding for the purpose of computing the 
percentage owned by any other shareholder.

(3)  Includes 351,581 shares held by Asset Management Associates 1984. Dr. 
Shoch, a director of the Company, is a general partner of AMC Partners 84, 
which is the general partner of Asset Management Associates 1984. Dr. Shoch 
disclaims beneficial ownership of the shares held by Asset Management 
Associates 1984 except to the extent of his pecuniary interest therein. 
Messrs. Franklin P. Johnson, Jr. and Craig C. Taylor are the other general 
partners of Asset Management Company and may be deemed beneficial owners of 
shares owned by Asset Management Associates 1984.

(4)  Includes 6,000 shares held and 28,812 shares in the form of immediately 
exercisable options held by Dr. Shoch of which 9,000 are subject to a 
repurchase right in favor of the Company that will lapse in a series of 
installments so long as Dr. Shoch remains in the service of the Company and 
351,581 shares held by Asset Management Associates 1984, as to which Dr. 
Shoch disclaims beneficial ownership except to the extent of his pecuniary 
interest therein. 

(5)  Includes 21,000 shares in the form of immediately exercisable options 
held by Mr. Cooper of which 9,000 are subject to a repurchase right in favor 
of the Company that will lapse in a series of installments so long as Mr. 
Cooper remains in the service of the Company.

(6)  Includes 18,000 shares in the form of immediately exercisable options 
held by Mr. Janowiak of which 12,750 are subject to a repurchase right in 
favor of the Company that will lapse in a series of installments so long as 
Mr. Janowiak remains in the service of the Company.

(7)  Includes 1,500 shares held and 21,000 shares in the form of immediately 
exercisable options held by Mr. Kaplan of which 13,500 are subject to a 
repurchase right in favor of the Company that will lapse in a series of 
installments so long as Mr. Kaplan remains in the service of the Company.

(8)  Includes 35,307 shares held in the Shalvoy Family Trust, 6,600 shares 
held in trust for minor children and 215,579 shares in the form of 
immediately exercisable options, of which 55,148 are subject to a repurchase 
right in favor of the Company that will lapse in a series of installments so 
long as Mr. Shalvoy remains in the service of the Company.

(9)  Includes 15,384 shares in the form of immediately exercisable options, 
of which 2,718 are subject to a repurchase right in favor of the Company that 
will lapse in a series of installments so long as Mr. Fowler remains in the 
service of the Company.

(10) Includes 15,384 shares in the form of immediately exercisable options.

(11) Includes 5,205 shares held and 64,930 shares in the form of immediately 
exercisable options, of which 8,884 shares are subject to a repurchase right 
in favor of the Company that will lapse in a series of installments so long 
as Dr. Simon remains in the service of the Company. 

(12) Includes 383,889 shares in the form of options exercisable at April 16, 
1998. See Notes (4), (5), (6), (7), (9), (10) and (11).

                                     -13-
<PAGE>

                               CONDUCTUS, INC.


             EXECUTIVE COMPENSATION AND RELATED INFORMATION 

                        EXECUTIVE COMPENSATION

The following table provides certain summary information concerning the 
compensation earned by the Company's Chief Executive Officer and each of its 
other four most highly compensated executive officers whose compensation was 
in excess of $100,000 (determined as of the end of the last fiscal year) for 
services rendered in all capacities to the Company for the fiscal year ended 
December 31, 1997 (collectively, "Named Officers"). No executive officers who 
would have otherwise been includable in such table on the basis of salary and 
bonus earned for the 1997 fiscal year have resigned or terminated employment 
during that fiscal year.

                          SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------------------------------
                                                      ANNUAL COMPENSATION                   LONG TERM COMPENSATION
- --------------------------------------------------------------------------------------------------------------------------
                                                                                                    AWARDS
- --------------------------------------------------------------------------------------------------------------------------
      NAME AND            YEAR                 SALARY                     BONUS         SECURITIES UNDERLYING OPTIONS (#)
 PRINCIPAL POSITION                            ($) (1)                   ($) (2)   
- --------------------------------------------------------------------------------------------------------------------------
<S>                       <C>                  <C>                       <C>                       <C>
Charles E. Shalvoy,       1997                 $197,088                  $11,000                       --
President and CEO         1996                  185,682                   64,600                       --
                          1995                  175,011                   31,669                       --
- --------------------------------------------------------------------------------------------------------------------------
William J. Fowler         1997                  114,128                    8,000                   40,000(6)
Vice President            1996(3)                31,879                    7,500                   40,000
                          1995                       --                       --                       --
- --------------------------------------------------------------------------------------------------------------------------
Graham Y. Mostyn          1997                  140,004                   18,000                   60,000(7)
Vice President            1996(4)                15,616                   10,000                   60,000
                          1995                       --                       --                       --
- --------------------------------------------------------------------------------------------------------------------------
Dennis Nau                1997(5)               130,915                       --                   50,000(8)
Vice President and        1996(5)                74,428                   10,000                   50,000
General Manager           1995                       --                       --                       --
- --------------------------------------------------------------------------------------------------------------------------
Randy W. Simon,           1997                  125,908                    5,000                   60,000(9)
Vice President            1996                  113,698                   23,664                   20,000
                          1995                  105,704                   21,612                    8,000
- --------------------------------------------------------------------------------------------------------------------------
</TABLE>

(1)  Salary includes amounts deferred pursuant to the Company's 401(k) Plan. 
(2)  Includes bonuses earned but not paid.
(3)  Includes salary from September 3, 1996, upon commencement of employment.
(4)  Includes salary from November 5, 1996, upon commencement of employment.
(5)  Includes salary from June 18, 1996, upon commencement of employment.  Mr.
     Nau's employment terminated on October 31, 1997. His stock options were
     canceled on January 30, 1998.
(6)  Includes options for 40,000 shares granted under a repricing program in 
     exchange for cancellation of options for an equal number of shares.
(7)  Includes options for 60,000 shares granted under a repricing program in 
     exchange for cancellation of options for an equal number of shares.
(8)  Includes options for 50,000 shares granted under a repricing program in 
     exchange for cancellation of options for an equal number of shares.
(9)  Includes options for 40,000 shares granted in exchange for cancellation 
     of options for an equal number of shares under a repricing program.

                     OPTION GRANTS IN LAST FISCAL YEAR

The following table contains information concerning the stock option grants 
made to each of the Named Officers for the fiscal year ended December 31, 
1997.


                                       -14-
<PAGE>
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------
                           INDIVIDUAL GRANTS                                         POTENTIAL REALIZABLE 
                                                                                       VALUE AT ASSUMED 
                                                                                     ANNUAL RATES OF STOCK
                                                                                     PRICE APPRECIATION FOR 
                                                                                         OPTION TERM (1)
- ------------------------------------------------------------------------------------------------------------
     NAME              NUMBER OF      PERCENT OF       EXERCISE        EXPIRATION     5% ($)       10% ($)
                      SECURITIES     TOTAL OPTIONS       PRICE            DATE
                      UNDERLYING      GRANTED TO       ($/SHARE)
                       OPTIONS       EMPLOYEES IN 
                      GRANTED (#)     FISCAL YEAR
- ------------------------------------------------------------------------------------------------------------
<S>                    <C>                <C>             <C>          <C>            <C>          <C>
William J. Fowler      40,000(2)           7.1            6.50         10/24/2006     153,057      382,234
                                         

Graham Mostyn          60,000(3)          10.6            6.50         11/5/2006      230,580      576,375
                                                

Dennis Nau             50,000(4)           8.8            6.50         10/24/2006     183,445      454,044


Randy Simon            20,000(5)           3.5            6.50          3/14/2006      70,436      172,873

                       20,000(6)           3.5            8.375         1/23/2007     105,340      266,952

                       20,000(7)           3.5            6.50          1/23/2007      79,056      198,839
- ------------------------------------------------------------------------------------------------------------
</TABLE>

(1)  There is no assurance provided to any executive officer or any other 
     holder of the Company's securities that the actual stock price 
     appreciation over the 10-year option term will be at the assumed 5% and 
     10% levels or at any other defined level.

(2)  Granted April 29, 1997, in exchange for cancellation of an option 
     granted October 24, 1996, to purchase the same number of shares at an 
     exercise price of $9.25 per share. The options are immediately 
     exercisable. The shares are subject to a repurchase right which lapses 
     as follows: as to 20% of the shares plus an additional 1.67% for each 
     month of service between October 24, 1997 and April 29, 1998, on April 
     29, 1998, and an additional 1.67% upon the completion of each month of 
     service thereafter until the repurchase right shall fully lapse upon the 
     completion of the fifth year of service from October 24, 1996.

(3)  Granted April 29, 1997, in exchange for cancellation of an option 
     granted November 5, 1996 to purchase the same number of shares at an 
     exercise price of $8.00 per share. The options are immediately 
     exercisable. The shares are subject to a repurchase right which lapses 
     as follows: as to 20% of the shares plus an additional 1.67% for each 
     month of service between November 5, 1997 and April 29, 1998, on April 
     29, 1998, and an additional 1.67% upon the completion of each month of 
     service thereafter until the repurchase right shall fully lapse upon the 
     completion of the fifth year of service from November 5, 1996.

(4)  Granted April 29, 1997, in exchange for cancellation of an option 
     granted October 24, 1996, to purchase the same number of shares at an 
     exercise price of $9.25 per share.  

(5)  Granted April 29, 1997, in exchange for cancellation of an option 
     granted March 14, 1996 to purchase the same number of shares at an 
     exercise price of $11.50. The options are immediately exercisable. The 
     shares are subject to a repurchase right which lapses as follows: as to 
     20% of the shares plus an additional 1.67% for each month of service 
     between March 14, 1997, and April 29, 1998, on April 29, 1998, and an 
     additional 1.67% upon the completion of each month of service thereafter 
     until the repurchase right shall fully lapse upon the completion of the 
     fifth year of service from March 14, 1996.

(6)  Granted January 23, 1997. Canceled April 29, 1997.

(7)  Granted April 29, 1997, in exchange for cancellation of an option 
     granted January 23, 1997, to purchase the same number of shares at an 
     exercise prices of $8.375. The options are immediately exercisable. The 
     shares are subject to a repurchase right which lapses as follows: as to 
     20% of the shares plus an additional 1.67% for each month of service 
     between January 23, 1998, and April 29, 1998, on April 29, 1998, and an 
     additional 1.67% upon the completion of each month of service thereafter 
     until the repurchase right shall fully lapse upon the completion of the 
     fifth year of service from January 23, 1997.


                                     -15-
<PAGE>

                               CONDUCTUS, INC.


            AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND 
                      FISCAL YEAR-END OPTION VALUES

The following table sets forth information concerning option exercises and 
option holdings at the end of the 1997 fiscal year with respect to the Named 
Officers. No options or SARs were exercised during the 1997 fiscal year, nor 
were any SARs outstanding at the end of such fiscal year.

<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------
                                                     NUMBER OF SECURITIES       VALUE OF UNEXERCISED IN-THE-
                                                    UNDERLYING UNEXERCISED         MONEY OPTIONS AT FISCAL 
                                                  OPTIONS AT FISCAL YEAR END           YEAR END (1) ($)
                                                             (#) 
- ------------------------------------------------------------------------------------------------------------
                          SHARES 
                         ACQUIRED      VALUE 
      NAME              ON EXERCISE   REALIZED    EXERCISABLE   UNEXERCISABLE   EXERCISABLE    UNEXERCISABLE
                            (#)         ($)           (2)
- ------------------------------------------------------------------------------------------------------------
<S>                       <C>          <C>           <C>           <C>            <C>              <C>
Charles E. Shalvoy        25,000       $37,500       114,998       110,002        $   -            $  -
William J. Fowler           -             -             -           40,000            -               -
Graham Y. Mostyn            -             -             -           60,000            -               -
Dennis Nau                  -             -           12,994          -               -               -
Randy Simon                 -             -           46,212        43,334         174,882          10,617
- ------------------------------------------------------------------------------------------------------------
</TABLE>

(1)     Calculated on the basis of the fair market value of the Common Stock 
        on December 31, 1997 of $5.063 per share, as reported on the NASDAQ 
        National Market, minus the exercise price.

(2)     Any unvested shares purchased under the option will be subject to 
        repurchase by the Company at the original exercise price per share 
        upon the optionee's cessation of service prior to vesting in such 
        shares.  As of December 31, 1997, the Company's repurchase right had 
        lapsed with respect to the following number of option shares: Mr. 
        Shalvoy - 99,998; Mr. Fowler - 0; Mr. Mostyn - 0; Mr. Nau - 12,994; 
        Dr. Simon - 40,523

      EMPLOYMENT CONTRACTS, TERMINATION OF EMPLOYMENT ARRANGEMENTS AND 
                       CHANGE IN CONTROL AGREEMENTS

None of the Company's executive officers have employment agreements with the 
Company, and their employment may be terminated at any time at the discretion 
of the Board. The 1992 Stock Option/Stock Issuance Plan provides for the 
accelerated vesting of the shares of Common Stock subject to outstanding 
options under certain circumstances. See "Proposal Three" above.

                   TEN-YEAR OPTION/SAR REPRICINGS

On April 29, 1997, the Compensation Committee and the Board of Directors 
approved a program under which employees who had elected to surrender those 
of their options which were above the closing price of the Company's common 
stock on April 29, 1997, would receive in exchange new options at the closing 
price on that date.  The new options would cover the same number of shares as 
the surrendered options, would have the same status under the tax laws as the 
surrendered options and would be non-vested until April 29, 1998, after which 
they would vest as provided in the original vesting schedule.  The repricing 
was undertaken to attract and retain employees while maintaining relatively 
low cash compensation.  Pursuant to the repricing program, the following 
table sets forth information concerning repricing of options held by any 
executive officer during the last ten completed fiscal years:


                                    -16-
<PAGE>

                               CONDUCTUS, INC.


<TABLE>
<CAPTION>
    NAME                 DATE         SECURITIES     MARKET PRICE     EXERCISE PRICE     NEW EXERCISE      LENGTH OF 
                                      UNDERLYING     OF STOCK AT        AT TIME OF         PRICE ($)       ORIGINAL 
                                      NUMBER OF        TIME OF         REPRICING OR                       OPTION TERM 
                                       OPTIONS       REPRICING OR       AMENDMENT                          REMAINING AT 
                                     REPRICED OR      AMENDMENT            ($)                               DATE OF 
                                     AMENDED (#)         ($)                                               REPRICING OR 
                                                                                                            AMENDMENT
<S>                     <C>            <C>              <C>               <C>              <C>              <C>
William Fowler         4/29/97         40,000           $6.50             $9.25            $6.50            9.5 years

Graham Mostyn          4/29/97         50,000            6.50              8.00             6.50            9.5 years

Dennis Nau             4/29/97         60,000            6.50              8.00             6.50            9.5 years

Randy Simon            4/29/97         20,000            6.50             11.50             6.50            8.9 years

                       4/29/97         20,000            6.50              8.375            6.50            9.8 years
</TABLE>

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

John F. Shoch, who became a member of the Compensation Committee of the Board 
of Directors in May 1993, is a general partner of AMC Partners 84, which is 
the general partner of Asset Management Associates 1984, the beneficial owner 
of more than five percent of the Company's Common Stock. Dr. Shoch served as 
Chief Executive Officer of the Company from September 1987 until October 
1988. 

                           CERTAIN TRANSACTIONS

In October 1988, Conductus entered into a five-year Coordinated Research 
Program Agreement with H-P. In June 1993, Conductus and H-P modified this 
agreement by entering into a new five-year agreement (the "Current H-P 
Agreement"). In addition, H-P has made a total equity investment of 
$6,230,000 in Conductus and beneficially owns more than 5% of the Company's 
Stock. See "Ownership of Securities."

The Current H-P Agreement requires Conductus and H-P to exchange reviews and 
assessments of Conductus' technical and applications developments, 
particularly with respect to their potential application to H-P's product 
lines. H-P has the right to appoint an H-P employee (the "H-P Member") as a 
member of the Company's Scientific Advisory Board. H-P will jointly own with 
Conductus any invention by the H-P Member acting pursuant to the Current H-P 
Agreement or using the Company's confidential information. 

The Company has entered into separate indemnification agreements with its 
directors and officers. These agreements require the Company, among other 
things, to indemnify them against certain liabilities that may arise by 
reason of their status or service as directors or officers (other than 
liabilities arising from actions not taken in good faith or in a manner the 
indemnitee believed to be opposed to the best interest of the Company), to 
advance their expenses incurred as a result of any proceeding against them as 
to which they could be indemnified and to obtain directors' and officers' 
insurance if available on reasonable terms.

                   COMPENSATION COMMITTEE REPORT

Notwithstanding anything to the contrary set forth in any of the Company's 
previous filings under the Securities Act of 1933 or the 1934 Act that might 
incorporate future filings, including this Proxy, in whole or in part, the 
following report and the Performance Graph which follows shall not be deemed 
to be incorporated by reference into any such filings.

Decisions on compensation of the Company's Chief Executive Officer, Charles 
E. Shalvoy, and its other executive officers are generally made by the 
Compensation Committee of the Company's Board of Directors. At the time of 
this report, the Compensation Committee consists of Dr. Shoch and Mr. Kaplan, 
two of the Company's outside directors. All decisions by the Compensation 
Committee are reviewed by the full Board of Directors, except for decisions 
about awards under the Company's 1992 Stock Option/Stock Issuance Plan. The 
Compensation Committee has furnished the following report on the 1997 
compensation of Charles E. Shalvoy and the Company's other executive officers.

                                     -17-
<PAGE>

                               CONDUCTUS, INC.


In setting the compensation levels, the Compensation Committee considers the 
standard practices in the superconductor industry, including data from 
surveys, as well as the practices of companies with whom the Company competes 
for executive talent. The Company believes that its total executive 
compensation package is near the median among its peers making the transition 
from the development stage, although it is low when compared to companies at 
a more advanced stage with whom the Company competes for talent.

It is the current philosophy of the Company to keep the base salary of 
executives between the 25th and 50th percentiles based on the RADFORD 
ASSOCIATES MANAGEMENT TOTAL COMPENSATION PLAN 1994 - OVERALL COMPANIES LESS 
THAN $40M (Radford), so that more of their compensation depends on bonuses, 
which are contingent upon Company and individual performance. The Radford 
surveys include some but not all companies included in the indices used in 
the Performance Graph. See "Comparison of Stockholder Return." The executives 
are thus motivated to enhance stockholder value. 

As the Company is just beginning to commercialize products, the Compensation 
Committee believes that corporate performance is not appropriately measured 
by traditional financial performance criteria such as profitability and 
earnings per share. Rather, the Compensation Committee believes that 
corporate performance is appropriately measured by analyzing the degree to 
which the Company has achieved certain goals established by the Compensation 
Committee and approved by the Board.

Under the Executive Compensation Bonus Plan (ECBP), an executive's annual 
incentive award depends on improved revenues, profit/loss results, milestone 
accomplishments and the executive's specific contribution. The current 
philosophy of the Company is to keep total compensation, including bonuses, 
for executives between the 50th and 75th percentiles of the companies in the 
Radford survey. The performance goals for the Company are derived from the 
Company's business plans that include critical individual performance targets 
relating to strategic product positioning, revenue growth, and profit/loss 
for the fiscal year and key milestones. The ECBP is based on a formula 
comprised of a Company Performance Ratio (CPR) multiple times an Individual 
Performance Ratio (IPR) multiple. The CPR is based on the ratio of actual 
versus plan performance for revenues and profit/loss and can range from 50% 
to 150%. The IPR is tied to achievement of goals during the year that are 
established in advance and may have a range from 0% to 100%. Multiplying the 
two, CPR x IPR then quantifies the executives' bonuses based on a 
predetermined target of 30% to 50% of base salary. The incentive target is 
set at a higher percentage for more senior officers, with the result that the 
more senior executive officers have a higher percentage of their potential 
cash compensation at risk. If the CPR is 150% and IPR equals 130%, executives 
can earn up to a maximum of 45% to 75% of their base salaries. The Committee 
annually reviews and approves specific bonus targets, maximums, and 
performance criteria for all executives. 

For 1997, the bonuses were reduced below the ECBP values due to the Company's 
performance and cash position during the first quarter of 1998.  The bonuses 
awarded ranged from 57% to 82% of the ECBP value.

STOCK OPTIONS

The Committee grants stock options under the Plan to foster executive 
ownership and to provide direct linkage with stockholder interests. The 
Committee considers the current level of equity holdings in the Company, 
stock options previously granted, industry practices, the executive's 
accountability level, and assumed potential stock value when determining 
stock option grants. The Committee relies upon competitive guideline ranges 
of retention-effective, target-gain objectives to be derived from option 
gains based upon relatively aggressive assumptions relating to planned growth 
and earnings. In this manner, potential executive gains parallel those of 
other stockholders over the long term. Therefore, the stock option program 
serves as the Company's primary long-term incentive and retention tool for 
executives and other key employees. The exercise prices of stock options 
granted to the executive officers are equal to the market value of the stock 
on the date of grant. 

REPRICING OF STOCK OPTIONS

On April 29, 1997, the Compensation Committee and the Board of Directors 
approved a program under which employees, including executive officers, who 
had elected to surrender those of their options which were above the closing 
price of the Company's common stock on April 29, 1997, would receive in 
exchange new options at the closing price on that date.  The new options 
would cover the same number of shares as the surrendered options, would have 
the same status under the tax laws as the surrendered options and would be 
non-vested until April 29, 1998, after which they would vest as provided in 
the original vesting schedule. The repricing was undertaken to attract and 
retain employees while maintaining relatively low cash compensation.


                                    -18-
<PAGE>

                               CONDUCTUS, INC.


CEO COMPENSATION

Mr. Shalvoy commenced employment with the Company effective June 6, 1994. In 
general, the factors utilized in determining Mr. Shalvoy's compensation are 
the same as those applied to the other executive officers in the manner 
described in the preceding paragraphs, although achievement of Company 
financial performance goals has a greater impact on his total compensation.

In establishing Mr. Shalvoy's base salary, it was the Committee's intent to 
provide him with a level of stability and certainty each year. His base 
salary for the 1997 fiscal year approximates the 40th percentile of reported 
base salaries for Chief Executive Officers based on Radford.

The annual bonus component of Mr. Shalvoy's compensation package was based on 
Company financial performance and individual goal achievement, as described 
under "Annual Bonus" above. Based upon Mr. Shalvoy's IPR and CPR multiples, 
his resultant bonus for 1997 would have been $41,000.  As with the other 
officers, Mr. Shalvoy's 1997 bonus was reduced below the ECBP value, and 
totaled $11,000, or 27% of the ECPB amount.

COMPLIANCE WITH INTERNAL REVENUE CODE SECTION 162(m)

Section 162(m) of the Internal Revenue Code, enacted in 1993, generally 
disallows a tax deduction to publicly held companies for compensation 
exceeding $1 million per year paid to certain of the corporation's executive 
officers. It is not expected that the compensation to be paid to the 
Company's executive officers for fiscal 1998 will exceed the $1 million limit 
per officer. The Compensation Committee will defer any decision on whether or 
not to limit the dollar amount of all compensation payable to the Company's 
executive officers to $1 million per year, should the individual compensation 
of any executive officer ever approach that level.

In summary, it is the opinion of the Committee that the adopted executive 
compensation policies and plans provide the necessary total remuneration 
program to properly align the Company's performance and the interest of the 
Company's stockholders with competitive and equitable executive compensation 
in a balanced and reasonable manner, for both the short and long term.


                                       JOHN F. SHOCH, Ph.D.
                                       Chairman, Compensation Committee


                                       MARTIN KAPLAN
                                       Member, Compensation Committee


                                     -19-
<PAGE>

                               CONDUCTUS, INC.


                     COMPARISON OF STOCKHOLDER RETURN

The graph depicted below reflects a comparison of the cumulative total return
(change in stock price plus reinvested dividends) of the Company's Common 
Stock together with the cumulative total returns of the Nasdaq Stock Market, 
U.S. Index and the Hambrecht & Quist Technology Index.



                                [GRAPH]



(1)  The graph covers the period from August 6, 1993, the date the Company's 
     initial public offering commenced, through the fiscal year ended 
     December 31, 1997.

(2)  The graph assumes that $100 was invested on August 6, 1993 in the 
     Company's Common Stock and in each index and that all dividends were 
     reinvested. No cash dividends have been declared on the Company's Common 
     Stock.

(3)  Stockholder returns over the indicated period should not be considered 
     indicative of future stockholder returns.

     COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934

Section 16(a) of the 1934 Act requires the Company's executive officers and 
directors and persons who own more than 10% of the Company's Common Stock to 
file certain reports of ownership with the Securities and Exchange Commission 
("SEC") and with the National Association of Securities Dealers.  Such 
officers, directors and stockholders are also required by SEC rules to 
furnish the Company with copies of all Section 16(a) forms that they file. 
Based upon (i) the copies of Section 16(a) reports which the Company received 
from such persons for their 1997 fiscal year transactions and (ii) the 
written representations received from one or more of such persons that no 
annual Form 5 reports were required to be filed for them for the 1997 fiscal 
year, the Company believes that all Section 16(a) filing requirements 
applicable to such officers, directors and 10% beneficial owners were 
complied with.

                                     -20-
<PAGE>

                               CONDUCTUS, INC.


              STOCKHOLDER PROPOSALS FOR 1999 ANNUAL MEETING

Stockholder proposals that are intended to be presented at the 1999 Annual 
Meeting that are eligible for inclusion in the Company's proxy statement and 
related proxy materials for that meeting under the applicable rules of the 
Securities and Exchange Commission must be received by the Company not later 
than February 26, 1999, in order to be included. Such stockholder proposals 
should be addressed to Conductus, Inc., 969 West Maude Avenue, Sunnyvale, 
California 94086, Attention: Corporate Secretary.

                           ANNUAL REPORT

A copy of the Annual Report of the Company for the fiscal year ended 
December 31, 1997, has been mailed concurrently with this Proxy Statement to 
all stockholders entitled to notice of and to vote at the Annual Meeting.

                            FORM 10-K/A

THE COMPANY FILED AN ANNUAL REPORT ON FORM 10-K/A WITH THE SEC. STOCKHOLDERS 
MAY OBTAIN A COPY OF THIS REPORT, WITHOUT CHARGE, BY WRITING TO DONALD 
DEPASCAL, CHIEF ACCOUNTING OFFICER, AT THE COMPANY'S EXECUTIVE OFFICES AT 969 
WEST MAUDE AVENUE, SUNNYVALE, CALIFORNIA 94086.

                                   THE BOARD OF DIRECTORS
                                   OF CONDUCTUS, INC.


                                      -21-
<PAGE>

                                 CONDUCTUS, INC.


                                 DIRECTIONS TO:
                                          
                         ANNUAL MEETING OF STOCKHOLDERS
                                          
                           TO BE HELD ON MAY 29, 1998
                                          
                                          


FROM SAN FRANCISCO AIRPORT

Follow signs to 101 South - Take 101 South approximately 35 miles to Mathilda 
Avenue South Exit - Take Mathilda South to Maude Avenue - Turn right onto 
Maude Avenue - Go down two traffic lights - Conductus' administrative offices 
are located at 965 West Maude Avenue on the right just before the third 
stoplight (Macara Avenue).


FROM SAN JOSE AIRPORT

Follow signs to 101 North - Take 101 North approximately 8 miles to Mathilda 
Avenue South Exit - Take Mathilda South to Maude Avenue - Turn right onto 
Maude Avenue - Go down two traffic lights - Conductus' administrative offices 
are located at 965 West Maude Avenue on the right just before the third 
stoplight (Macara Avenue).
<PAGE>

                  AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
                                 OF CONDUCTUS, INC.
                               a Delaware Corporation
                                          
                      (Pursuant to sections 242 and 245 of the
                          Delaware General Corporation Law)
                                          
          Conductus, Inc. (the "Corporation"), a corporation organized and
existing under the General Corporation Law of the State of Delaware (the
"General Corporation Law") does hereby certify that:

          FIRST:  The name of the Corporation is Conductus, Inc. and that the
Corporation was originally incorporated on September 1, 1987 pursuant to the
General Corporation Law; and

          SECOND:  The following resolutions amending and restating the 
Corporation's Restated Certificate of Incorporation, as amended, were 
approved by the Board of Directors of the Corporation by unanimous written 
consent effective as of April 28, 1998 and were duly adopted by the 
stockholders of the Corporation in accordance with the provisions of Sections 
242 and 245 of the General Corporation Law at a meeting of the stockholders 
held in accordance with Section 228 of the General Corporation Law:

               "Now, therefore, be it resolved that the Restated
          Certificate of Incorporation of the Corporation, as amended, be
          amended and restated in its entirety as follows:

                                     ARTICLE I

          The name of the Corporation (herein called the "Corporation") is
CONDUCTUS, INC.

                                     ARTICLE II

          The address of the registered office of the Corporation in the State
of Delaware is 32 Loockerman Square, Suite L-100, in the City of Dover, County
of Kent.  The name of its registered agent at such address is The Prentice-Hall
Corporation System, Inc. 

                                    ARTICLE III

          The nature of the business or purposes to be conducted or promoted is
to engage in any lawful act or activity for which corporations may be organized
under the General Corporation Law of Delaware.
<PAGE>
                                     ARTICLE IV

          A.   CLASSES OF STOCK.  The Corporation is authorized to issue two
classes of stock to be designated, respectively, "Common Stock" and "Preferred
Stock." The total number of shares that the Corporation is authorized to issue
is Twenty-Five Million (25,000,000) shares.  Twenty Million (20,000,000) shares,
par value of one hundredths of a cent ($.0001) per share, shall be Common Stock,
and Five Million (5,000,000) shares, par value of one hundredth of a cent
($.0001) per share, shall be Preferred Stock.

          B.   RIGHTS, PREFERENCES AND RESTRICTIONS OF PREFERRED STOCK.  The
Preferred Stock authorized by this Restated Certificate of Incorporation may be
issued from time to time in one or more series.  The Board of Directors is
hereby authorized to fix or alter the rights, preferences, privileges and
restrictions granted to or imposed upon any series of Preferred Stock, and the
number of shares constituting any such series and the designation thereof, or of
any of them.  Subject to compliance with applicable protective voting rights
that have been or may be granted to the Preferred Stock or series thereof in
Certificates of Determination or the Corporation's Certificate of Incorporation
("Protective Provisions"), but notwithstanding any other rights of the Preferred
Stock or any series thereof, the rights, privileges, preferences and
restrictions of any such additional series may be subordinated to, PARI PASSU
with (including, without limitation, inclusion in provisions with respect to
liquidation and acquisition preferences, redemption and/or approval of matters
by vote or written consent), or senior to any of those of any present or future
class or series of Preferred or Common Stock.  Subject to compliance with
applicable Protective Provisions, the Board of Directors is also authorized to
increase or decrease the number of shares of any series, prior or subsequent to
the issue of that series, but not below the number of shares of such series then
outstanding.  In case the number of shares of any series shall be so decreased,
the shares constituting such decrease shall resume the status that they had
prior to the adoption of the resolution originally fixing the number of shares
of such series.

          C.   COMMON STOCK.

          1.   DIVIDEND RIGHTS.  Subject to any preferential dividend rights
applicable to the shares of the Preferred Stock, the holders of shares of the
Common Stock shall be entitled to receive such dividends as may be declared from
time to time by the Board of Directors.

          2.   LIQUIDATION RIGHTS.  In the event of any voluntary or involuntary
liquidation, dissolution or winding up of the Corporation, after distribution in
full of the preferential amounts to be distributed to the holders of shares of
the Preferred Stock, the holders of shares of the Common Stock shall be entitled
to receive all of the remaining assets of the  Corporation available for
distribution to its stockholders, ratably in proportion to the number of shares
of the Common Stock held by them.

          3.   REDEMPTION.  The Common Stock is not redeemable.

          4.   VOTING RIGHTS.  The holders of shares of Common Stock shall be
entitled to vote on all matters at all meetings of the stockholders of the
Corporation and shall be entitled to one vote for each share of Common Stock
entitled to vote at such meeting.

                                       2
<PAGE>
                                     ARTICLE V

          Except as otherwise provided in this Restated Certificate of
Incorporation, in furtherance and not in limitation of the powers conferred by
statute, the Board of Directors is expressly authorized to make, repeal, alter,
amend and rescind any or all of the Bylaws of the Corporation.

                                     ARTICLE VI

          The number of directors of the Corporation shall be fixed from time to
time by a bylaw or amendment thereof duly adopted by the Board of Directors or
by the stockholders of the Corporation.

                                    ARTICLE VII

          Elections of directors need not be by written ballot unless the Bylaws
of the Corporation shall so provide.

                                    ARTICLE VIII

          Meetings of stockholders may be held within or without the State of
Delaware, as the Bylaws may provide.  The books of the Corporation may be kept
(subject to any provision contained in the statutes) outside the State of
Delaware at such place or places as may be designated from time to time by the
Board of Directors or in the Bylaws of the Corporation.

                                     ARTICLE IX

          No action may be taken by the stockholders of the Corporation without
a meeting, and no consents in lieu of a meeting may be taken pursuant to Section
228 of the Delaware General Corporation Law.

                                     ARTICLE X

          A director of the Corporation shall not be personally liable to the
Corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, except for liability (i) for any breach of the director's
duty of loyalty to the Corporation or its stockholders, (ii) for acts or
omissions not in good faith or that involve intentional misconduct or a knowing
violation of law, (iii) under Section 174 of the Delaware General Corporation
Law, or (iv) for any transaction from which the director derived any improper
personal benefit.  If the Delaware General Corporation Law is hereafter amended
to authorize, with the approval of a corporation's stockholders, further
reductions in the liability of the Corporation's directors for breach of
fiduciary duty, then a director of the Corporation shall not be liable for any
such breach to the fullest extent permitted by the Delaware General Corporation
Law as so amended.  Any repeal or modification of the foregoing provisions of
this Article X by the stockholders of the Corporation shall not adversely affect
any right or protection of a director of the Corporation existing at the time of
such repeal or modification.

                                      3

<PAGE>
                                     ARTICLE XI

          The Corporation reserves the right to amend, alter, change or repeal
any provision contained in this Restated Certificate of Incorporation, in the
manner now or hereafter prescribed by statute, and all rights conferred upon
stockholders herein are granted subject to this reservation.

                                      4

<PAGE>

          IN WITNESS WHEREOF, CONDUCTUS, INC. has caused this Amended and
Restated Certificate of Incorporation to be signed by its President and attested
to by its Secretary this __ day of _____, 1998.
                         
                                   

                                   ----------------------------------------
                                   CHARLES E. SHALVOY, President
                                   and Chief Executive Officer

ATTEST:
          

- -------------------------------
JUDITH A. DEFRANCO
Secretary

<PAGE>

                               CONDUCTUS, INC.

                                    PROXY

                Annual Meeting of Stockholders, May 29, 1998

        This Proxy is Solicited on Behalf of the Board of Directors of
                               Conductus, Inc.

     The Undersigned revokes all previous proxies, acknowledges receipt of 
the Notice of the Annual Meeting of Stockholders to be held May 29, 1998 and 
the Proxy Statement and appoints Charles E. Shalvoy and Judith A. DeFranco 
and each of them, the Proxy of the undersigned, with full power of 
substitution, to vote all shares of Common Stock of Conductus, Inc. (the 
"Company") which the undersigned is entitled to vote, either on his or her 
own behalf or on behalf of any entity or entities, at the Annual Meeting of 
Stockholders of the Company to be held at the Company's offices located at 
969 W. Maude Avenue, Sunnyvale, California on Friday, May 29 at 3:00 p.m. 
(the "Annual Meeting"), and at any adjournment or postponement thereof, with 
the same force and effect as the undersigned might or could do if personally 
present thereat. The shares represented by this Proxy shall be voted in the 
manner set forth on the reverse side.

                CONTINUED AND TO BE SIGNED ON REVERSE SIDE
- -------------------------------------------------------------------------------

<PAGE>

     1.  To elect the following directors to serve for a term ending upon the 
1999 Annual Meeting of stockholders indicated beside their respective names 
and until their successors are elected and qualified:

         / / FOR ALL NOMINEES

         / / WITHHOLD AUTHORITY TO VOTE FOR ALL NOMINEES

         / / FOR ALL NOMINEES, EXCEPT AS NOTED ABOVE

     2.  FOR     AGAINST     ABSTAIN       To approve the amendment and 
                                           restatement of the Company's 
                                           Restated Certificate of 
                                           Incorporation to (i) increase the 
                                           number of shares of Common Stock 
                                           authorized to be issued from 
                                           11,000,000 to 20,000,000, and (ii) 
                                           increase the number of shares of 
                                           Preferred Stock authorized to be 
                                           issued from 1,000,000 to 5,000,000.
                                           

     3.  FOR     AGAINST     ABSTAIN       To approve the Company's Amended and 
                                           Restated 1992 Stock Option/Stock
                                           Issuance Plan to change the maximum
                                           number of shares which may be granted
                                           to a single individual to 750,000 in
                                           any one calendar year from 240,000
                                           over the life of the Plan and to
                                           permit discretionary option grants
                                           to non-employee directors.

     4.  FOR     AGAINST     ABSTAIN       To ratify the Board of Director's 
                                           selection of Coopers & Lybrand to 
                                           serve as the Company's independent 
                                           auditors for the fiscal year 
                                           ending December 31, 1998 and 


     5.  FOR     AGAINST     ABSTAIN       To transact such other business as 
                                           may properly come before the 
                                           Annual Meeting or any adjournment 
                                           or postponement thereof.

     The Board of Directors recommends a vote FOR each of the nominees listed 
above and a vote FOR the other proposals. This Proxy, when properly executed, 
will be voted as specified above. THIS PROXY WILL BE VOTED FOR THE ELECTION 
OF THE NOMINEES LISTED ABOVE AND FOR THE OTHER PROPOSALS IF NO SPECIFICATION 
IS MADE.

Please print the name(s) appearing on each 
share certificate(s) over which you have
voting authority:                             ________________________________
                                              (Print name(s) on certificate)


Please sign your name:  _______________________________  Date: _______________
                        (Authorized Signature(s)) 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission